Cargando…

Role of hepatitis B virus in development of hepatocellular carcinoma: Focus on covalently closed circular DNA

Chronic infection with hepatitis B virus (HBV) remains a major global health problem, especially in developing countries. It may lead to prolonged liver damage, fibrosis, cirrhosis, and hepatocellular carcinoma. Persistent chronic HBV infection is related to host immune response and the stability of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bianca, Claryssa, Sidhartha, Elizabeth, Tiribelli, Claudio, El-Khobar, Korri Elvanita, Sukowati, Caecilia H C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9157711/ https://www.ncbi.nlm.nih.gov/pubmed/35721287 http://dx.doi.org/10.4254/wjh.v14.i5.866

Ejemplares similares

Immunotherapy against programmed death-1/programmed death ligand 1 in hepatocellular carcinoma: Importance of molecular variations, cellular heterogeneity, and cancer stem cells
por: Sukowati, Caecilia H C, et al.
Publicado: (2021)

Updates on Organoid Model for the Study of Liver Cancer
por: El-Khobar, Korri E., et al.
Publicado: (2023)

Activation of hepatic stem cells compartment during hepatocarcinogenesis in a HBsAg HBV-transgenic mouse model
por: Anfuso, Beatrice, et al.
Publicado: (2018)

Circulating Long and Circular Noncoding RNA as Non-Invasive Diagnostic Tools of Hepatocellular Carcinoma
por: Sukowati, Caecilia H. C., et al.
Publicado: (2021)

Sorafenib Resistance in Hepatocellular Carcinoma: The Relevance of Genetic Heterogeneity
por: Cabral, Loraine Kay D., et al.
Publicado: (2020)

Prognostic value of inflammatory markers in patients with COVID-19 in Indonesia
por: Prasetya, Ignatius Bima, et al.
Publicado: (2021)

PD-L1 Downregulation and DNA Methylation Inhibition for Molecular Therapy against Cancer Stem Cells in Hepatocellular Carcinoma
por: Sukowati, Caecilia, et al.
Publicado: (2023)

Improving Linkage to Care of Hepatitis C: Clinical Validation of GeneXpert(®) HCV Viral Load Point-of-Care Assay in Indonesia
por: Thedja, Meta Dewi, et al.
Publicado: (2021)

Research progress in hepatitis B virus covalently closed circular DNA
por: Zhang, Xiaodong, et al.
Publicado: (2022)

Approaches to quantifying hepatitis B virus covalently closed circular DNA
por: Zhang, Henrik, et al.
Publicado: (2022)

Quantification of Pregenomic RNA and Covalently Closed Circular DNA in Hepatitis B Virus-Related Hepatocellular Carcinoma
por: Bai, Fugui, et al.
Publicado: (2013)

Aptamer: A potential oligonucleotide nanomedicine in the diagnosis and treatment of hepatocellular carcinoma
por: Ladju, Rusdina Bte, et al.
Publicado: (2017)

Correction: Aptamer: A potential oligonucleotide nanomedicine in the diagnosis and treatment of hepatocellular carcinoma
por: Ladju, Rusdina Bte, et al.
Publicado: (2018)

Detection of HBV Covalently Closed Circular DNA
por: Li, Xiaoling, et al.
Publicado: (2017)

The Expression of CD90/Thy-1 in Hepatocellular Carcinoma: An In Vivo and In Vitro Study
por: Sukowati, Caecilia Hapsari Ceriapuri, et al.
Publicado: (2013)

Conversion of hepatitis B virus relaxed circular to covalently closed circular DNA is supported in murine cells
por: Wei, Lei, et al.
Publicado: (2022)

The Relevance of SOCS1 Methylation and Epigenetic Therapy in Diverse Cell Populations of Hepatocellular Carcinoma
por: Cabral, Loraine Kay D., et al.
Publicado: (2021)

Dynamics of Hepatitis B Virus Covalently Closed Circular DNA: A Mini-Review
por: Hu, Jie-Li, et al.
Publicado: (2023)

Gene and functional up-regulation of the BCRP/ABCG2 transporter in hepatocellular carcinoma
por: Sukowati, Caecilia HC, et al.
Publicado: (2012)

Differences in sequences between HBV-relaxed circular DNA and covalently closed circular DNA
por: Rybicka, Magda, et al.
Publicado: (2017)

DNA Polymerase alpha is essential for intracellular amplification of hepatitis B virus covalently closed circular DNA
por: Tang, Liudi, et al.
Publicado: (2019)

The role of multipotent cancer associated fibroblasts in hepatocarcinogenesis
por: Sukowati, Caecilia Hapsari Ceriapuri, et al.
Publicado: (2015)

Association of Hepatitis B Virus Covalently Closed Circular DNA and Human APOBEC3B in Hepatitis B Virus-Related Hepatocellular Carcinoma
por: Luo, Xuan, et al.
Publicado: (2016)

PCR mediated recombination impacts the analysis of hepatitis B Virus covalently closed circular DNA
por: Suspène, Rodolphe, et al.
Publicado: (2016)

New Insights on Molecular Mechanism of Hepatitis B Virus Covalently Closed Circular DNA Formation
por: Marchetti, Alexander L., et al.
Publicado: (2020)

Silencing hepatitis B virus covalently closed circular DNA: The potential of an epigenetic therapy approach
por: Singh, Prashika, et al.
Publicado: (2021)

A Novel Mouse Model Harboring Hepatitis B Virus Covalently Closed Circular DNA
por: Xu, Zaichao, et al.
Publicado: (2021)

CRISPR/Cas13-assisted hepatitis B virus covalently closed circular DNA detection
por: Zhang, Xiangying, et al.
Publicado: (2022)

Hepatitis B Virus Capsid: The Core in Productive Entry and Covalently Closed Circular DNA Formation
por: Mendenhall, Megan A., et al.
Publicado: (2023)

Functional cure of hepatitis B requires silencing covalently closed circular and integrated hepatitis B virus DNA
por: Ghany, Marc G., et al.
Publicado: (2022)

The role of host DNA ligases in hepadnavirus covalently closed circular DNA formation
por: Long, Quanxin, et al.
Publicado: (2017)

Persistence of hepatitis B virus covalently closed circular DNA in hepatocytes: molecular mechanisms and clinical significance
por: Yang, Hung-Chih, et al.
Publicado: (2014)

Role of Hepatitis B virus capsid phosphorylation in nucleocapsid disassembly and covalently closed circular DNA formation
por: Luo, Jun, et al.
Publicado: (2020)

Rapamycin inhibits hepatitis B virus covalently closed circular DNA transcription by enhancing the ubiquitination of HBx
por: Zhang, Yuan, et al.
Publicado: (2022)

Serum Stem Cell Growth Factor Beta for the Prediction of Therapy Response in Hepatocellular Carcinoma
por: Sukowati, Caecilia H. C., et al.
Publicado: (2018)

DNA Polymerase κ Is a Key Cellular Factor for the Formation of Covalently Closed Circular DNA of Hepatitis B Virus
por: Qi, Yonghe, et al.
Publicado: (2016)

Involvement of Host ATR-CHK1 Pathway in Hepatitis B Virus Covalently Closed Circular DNA Formation
por: Luo, Jun, et al.
Publicado: (2020)

Intracellular interferon signalling pathways as potential regulators of covalently closed circular DNA in the treatment of chronic hepatitis B
por: Goh, Zhi Yi, et al.
Publicado: (2021)

The Expression Level of ABCC6 Transporter in Colon Cancer Cells Correlates with the Activation of Different Intracellular Signaling Pathways
por: Abruzzese, Vittorio, et al.
Publicado: (2022)

Effects of Entecavir on Hepatitis B Virus Covalently Closed Circular DNA in Hepatitis B e Antigen-Positive Patients with Hepatitis B
por: Shi, Ming, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_jiuur08rg2cek8sphchofbcafn